The effect of cytosine arabinoside on platelet aggregation. 1976

R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi

Platelet aggregation induced by ADP, collagen, epinephrine, and thrombin was studied in patients with acute leukemia in complete remission, before and after a continuous 5-day intravenous infusion of cytosine arabinoside at a dose of 100 mg/m2 per day. Aggregation was also measured in normal subjects with cytosine arabinoside added in vitro. Cytosine arabinoside had no significant effect on platelet aggregation after either in vitro or in vivo administration.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
July 1970, Vnitrni lekarstvi,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
January 1973, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
June 1986, American journal of hematology,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
January 1974, Neoplasma,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
December 1976, Cancer treatment reports,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
June 1985, Seminars in oncology,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
January 1977, Biochemical and biophysical research communications,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
February 1969, Biochemical and biophysical research communications,
R G Gagliano, and A M Terrebonne, and J B Alperin, and J J Costanzi
August 1974, Experientia,
Copied contents to your clipboard!